Broncus Holding Corporation (2216.HK)

HKD 2.3

(4.55%)

EBITDA Summary of Broncus Holding Corporation

Broncus Holding Corporation's latest annual EBITDA in 2023 was -25.06 Million USD , up 1.24% from previous year.
Broncus Holding Corporation's latest quarterly EBITDA in 2024 Q2 was -4.82 Million USD , down 0.0% from previous quarter.
Broncus Holding Corporation reported an annual EBITDA of -25.51 Million USD in 2022, up 89.09% from previous year.
Broncus Holding Corporation reported an annual EBITDA of -233.31 Million USD in 2021, down -404.22% from previous year.
Broncus Holding Corporation reported a quarterly EBITDA of -4.82 Million USD for 2024 Q2, down 0.0% from previous quarter.
Broncus Holding Corporation reported a quarterly EBITDA of N/A for 2023 FY, up 1.24% from previous quarter.

Annual EBITDA Chart of Broncus Holding Corporation (2023 - 2019)

Historical Annual EBITDA of Broncus Holding Corporation (2023 - 2019)

Year	EBITDA	EBITDA Growth
2023	-25.06 Million USD	1.24%
2022	-25.51 Million USD	89.09%
2021	-233.31 Million USD	-404.22%
2020	-45.94 Million USD	-54.28%
2019	-29.95 Million USD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-4.82 Million USD	36.56%
2024 Q2	-4.82 Million USD	0.0%
2023 FY	- USD	1.24%
2023 Q4	-7.6 Million USD	0.0%
2023 Q3	-7.6 Million USD	4.22%
2023 Q2	-7.94 Million USD	0.0%
2023 Q1	-7.94 Million USD	-3.92%
2022 Q2	-7.64 Million USD	0.0%
2022 Q1	-7.64 Million USD	15.67%
2022 FY	- USD	89.09%
2022 Q4	-7.64 Million USD	0.0%
2022 Q3	-7.64 Million USD	0.03%
2021 Q4	-9.06 Million USD	0.0%
2021 Q2	-9.85 Million USD	0.0%
2021 Q1	-9.85 Million USD	-80.93%
2021 FY	- USD	-404.22%
2021 Q3	-9.06 Million USD	8.01%
2020 Q2	-4.35 Million USD	0.0%
2020 FY	- USD	-54.28%
2020 Q4	-5.44 Million USD	0.0%
2020 Q3	-5.44 Million USD	-24.96%
2020 Q1	-4.35 Million USD	0.0%
2019 FY	- USD	0.0%

Peer EBITDA Comparison of Broncus Holding Corporation

Name	EBITDA	EBITDA Difference
Vincent Medical Holdings Limited	104.43 Million HKD	123.996%